Skip to main content

Bank of New York Mellon Corp

Bank

Position in INBX — Inhibrx Biosciences, Inc.

CIK 1390777 NEW YORK, NY

Position in INBX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,482,448
+$742,940 QoQ
Shares Held
26,200
+1.3% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 161 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in INBX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. INBX ranks #136 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INBX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,482,448 26,200
2026-03-31 $1,739,508 25,874
2025-12-31 $2,113,092 26,748
2025-09-30 $1,688,209 50,125
2025-06-30 $720,319 50,478
2025-03-31 $738,670 52,800
2024-12-31 $792,253 51,445
2024-09-30 $402,977 25,733
2024-06-30 $443,888 31,326